Document Type: Original Article

Authors

1 Department of Pure & Industrial Chemistry, University of Nigeria, Nsukka, 410001, Enugu State, Nigeria

2 Department of Pure & Industrial Chemistry, University of Nigeria, Nsukka, Nigeria

3 Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, 410001, Nsukka, Enugu State, Nigeria

Abstract

Synthesis of new medicinally important phenylsulphonyl aminoalkanamides and N-aryl p-toluene sulphonamides is reported. The reaction between benzenesulphonylchloride 7 with valine gave 3-methyl-2-[phenylsulphonyl)amino]butanoic acid 9 which is converted into 2-[acetyl (phenylsulphonyl) amino]-3-methyl butanoic acid 10 by reaction with acetic anhydride in acetic acid. The reaction of the later with SOCl2 and subsequently with NH3 afforded 2-[N-acetyl (phenylsulphonyl) amino]-3-methyl butanamide intermediate 11. The palladium catalysed reaction of the intermediate with readily available aryl chlorides and bromides afforded a variety of phenyl sulphonylaminoalkanamides 13a-c. In another synthesis, p-toluenesulphonylchloride (14) reacted with aqueous ammonia to give 4-methyl benzenesulphonamide 15 which is converted into N-(4-hydroxylphenyl)-4-methylbenzene sulphonamide 17a, N-(4-formyl phenyl)-4-methyl benzene sulphonamide 17b, N-(4-aminophenyl)-4-methyl benzenesulphonamide 17c, 4-methyl-N-(2-methylphenyl) benzene sulphonamide 17d, N-(4-Methoxyphenyl)-4-methyl benzenesulphonamide 17e in good yields, by reaction with 4-chlorophenol, 4-bromobenzaldehyde , 4-bromoaniline, 2-chlorotoluene and 1-bromo-2-methoxybenzene, respectively. Structures of the synthesized compounds were confirmed by spectroscopic and elemental analytical data

Graphical Abstract

Keywords

Main Subjects

1.  M.J. Yelland, C.J. Nikles, N. McNairn, C.B. Delmar, P.J. Schulter, R.M. Brown, A series of Rheumatology, 2004, 46:135.

2. G. Loncode, N. Pommery, V. Depreux, J. Enzyme, Inhibitor Med. Chem., 2003, 5:18

3. R. Ronn, Y.A. Sabnis, T. Gossas, E. Akerblom, U.H. Danielson, A. Hallberg, A. Johnson, Bioorg. Med. Chem. Lett., 2006, 14:544

4. P. Verhaeghe, N. Azas, M. Gasquent, S. Hutter, C. Ducros, M. Laget, S. Rault, P. Rathelot, P. Vanelle, Bioorg. Med. Chem. Lett., 2008, 18:396.

5. L.L. William, JAMA., 2000, 346:393

6. F.C. Hans, E. Jawetz, B. G (Ed) Appleton Lange, 1998, 4, 761.

7. J. Kumes, J. Bazant, M. Pour, K. Waisser, M. Slosarek, J. Janota, Farma co, 55 (2000) 725 – 729.

8. D.W. Hopper, M.D. Vera, J. Sabatini, J.S. Xiang, M. Ipeg, Bioorg. Med. Chem. Lett., 2009, 19:2487.

9. J. De Ruiter, R.F. Borne, C.A. Mayfield, J. Med. Chem., 1989, 32:145.

10. U.J. Doxepine, Elsevier, 2006, 81-84.

11. K.A. Jones, M. Hatori , L.S. Mure, J.R. Bramley, R. Artymyshyn , S.P. Hong , M. Marzabadi ,  H. Zhong , J. Sprouse, Q. Zhu, A.T. Hartwick, , P.J. Sollars, G.E. Pickard , S.Panda , Nat. Chem. Biol., 2013, 9, 630.

12. R.D. Tung, M.A. Murcko, G.R. Bhisetti, Sulphonamides inhibitors of HIV-Asparty Protease  (2007) EP0659181, US  5585397.

13.  O. Skold, Sulphonamide resistance: mechanisms and trends, Drug resistance updates, 2000, 3, 155.

14. O. Skold,  Resistance to trimethoprim and sulphonamides, Veterinary research, 2001, 32:261.

15. G.A. Khodarahmi, C.S. Chen, G.H. Hakimelahi, C.T. Tseng, J. W. Chen., J.  Iranian Chemistry Society., 2005, 2, 124.

16. U.R. Aziz, T. Wajecha, A.A. Muhammed, A. Sumbal, M.K. Khalid, A. Muhammed, A. Hukhar, Int. J.  Chem. Res., 2011, 3, 99.

17. D. Steinhilber, Curr. Med. Chem., 1999, 6, 71.

18. R.S. Vardanyan, V.J. Hruby, Elsevier, 2006, 21, 277.

19. L. Beregi, P. Hugon, Sythesis of Essential Drugs, 1971, 3, 565.

20. S.S. Rindhe, B.K. Karale, R. Gupta,  M.A. Rode, Indian J. Pharm Sci., 2011, 73, 292.

21. S.M. Sondhi, R. Rani, O.P. Gupta, S.K. Agrawal, A.K. Sexena, Mol. Divers., 2009, 13, 357.

22. N.A. Nassir, Y.A. Mohammed, A. Zanariah, Molecules, 2013, 18, 11978.

23. B.P. Navin, N.P. Virendra, R.P. Hemant, M.F. Shaikh, J.C. Patel, Acta Pol. Pharm., 2010, 3,  267.

24. Z. Chen, W. Xu, K. Lu, S. Yang, H. Fan, P. S. Bhadurg, D. Hu, Y. Zhang, Molecule 2010, 15, 9046.

25. D.I. Ugwu, U.C. Okoro, P.O. Ukoha, S. Okafor, A. Ibezim, N.M. Kumar, Eur. J. Med. Chem., 2017, 135, 349.

26. S. Ali, A.J.  Qasir, K.Y. Saor, Iraqi J. Mark. Rec. Cons. Protection., 2009, 1, 1.

26. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, K.D. Kopple, J. Med. Chem., 2002, 45, 2615.  doi: 10.1021/jm020017n PMID: 12036371

27. W.H. de Van, G. Camenish, G. Folkers, J.R. Chretien, O.A. Raevsky, J. Drug. Target., 1998, 6, 151. doi: 10.3109/10611869808997889 PMID: 9886238

28. Q. Dong,  D.R. Dougan, X. Gong, P.  Halkowycz,  B. Jin,  T. Kanouni,  S. M. O'Connell,  N. Scorah, L. Shi, M.B. Wallace, F.  Zhou, Bioorg. Med. Chem. Lett., 2011, 21, 1315. DOI: 10.1016/j.bmcl.2011.01.071

29. S.D. Barrett, A.J.  Bridges, C.M.  Flamme, M. Kaufam, A.M. Doherty, R.M. Kennedy, D. Marston, W.A. Howard, Y. Smith, J. S. Warmus, H.  Tecle, D.T. Dudley, A.R. Saltiel, J.H. Fergus, A. M. Delaney, S. Lepage, W.R. Leopold, S.A.  Przybranowski, J.  Sebolt-Leopold, K. Van Becelaere,  Bioorg. Med. Chem. Lett., 2008, 18, 6501.

30. ACD/Structure Elucidator, version 15.01, Advanced Chemistry Development, Inc., Toronto, ON, Canada (www.acdlabs.com, 2015.)

31.  N. O’Boyle, M. Banck,  C.A. James, C.  Morley, T. Vandermeersch, G.R. Hutchchison,  J. Chemoinformatics., 2011, 3:33. doi: 10.1186/1758-2946-3-33.

32.  S.P. Dilber, Z.S.  Žižak, T.P.  Stojković, Z.D.  Juranić, B.J.  Drakulić, I.O.  Juranić, Int. J. Mol. Sci., 2007, 8:214.

33.  J. Gasteiger, M.  Marsili, Tetrahedron, 1980, 36:3219 

34.  G.M. Morris, D.S. Goodsell, R.S. Halliday,R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, J.  Comput Chem., 1998, 19, 1639.